CECCHETTI, Violetta
 Distribuzione geografica
Continente #
NA - Nord America 7.791
AS - Asia 5.789
EU - Europa 5.767
SA - Sud America 766
AF - Africa 150
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.288
Nazione #
US - Stati Uniti d'America 7.654
SG - Singapore 2.498
IT - Italia 1.032
UA - Ucraina 902
IE - Irlanda 869
CN - Cina 849
VN - Vietnam 777
RU - Federazione Russa 736
HK - Hong Kong 731
SE - Svezia 659
BR - Brasile 596
DE - Germania 362
FI - Finlandia 270
FR - Francia 261
GB - Regno Unito 200
KR - Corea 197
IN - India 123
BE - Belgio 112
TR - Turchia 111
JP - Giappone 81
PL - Polonia 72
BD - Bangladesh 65
AR - Argentina 59
CA - Canada 57
MX - Messico 57
IQ - Iraq 55
NL - Olanda 45
RO - Romania 45
UZ - Uzbekistan 45
ZA - Sudafrica 41
PK - Pakistan 38
CH - Svizzera 37
SA - Arabia Saudita 36
ES - Italia 35
ID - Indonesia 33
AT - Austria 29
CZ - Repubblica Ceca 26
EC - Ecuador 26
PH - Filippine 25
VE - Venezuela 21
EG - Egitto 20
MA - Marocco 18
CO - Colombia 17
CL - Cile 14
LB - Libano 14
AU - Australia 13
CI - Costa d'Avorio 13
ET - Etiopia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
MY - Malesia 12
IL - Israele 11
JO - Giordania 10
LT - Lituania 10
UY - Uruguay 10
BG - Bulgaria 9
TN - Tunisia 9
DZ - Algeria 8
GR - Grecia 8
PY - Paraguay 8
DK - Danimarca 7
EU - Europa 7
IR - Iran 7
KG - Kirghizistan 7
LV - Lettonia 7
AL - Albania 6
BO - Bolivia 6
NP - Nepal 6
PA - Panama 6
PE - Perù 6
JM - Giamaica 5
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
HN - Honduras 4
KZ - Kazakistan 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
AO - Angola 3
BY - Bielorussia 3
HR - Croazia 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
Totale 20.262
Città #
Singapore 1.848
Chandler 1.091
Dublin 869
Hong Kong 714
San Jose 663
Dong Ket 487
Ashburn 483
Jacksonville 483
Perugia 467
San Mateo 460
Boardman 307
Santa Clara 269
Moscow 206
Medford 205
Princeton 203
Beijing 197
Seoul 193
Lauterbourg 178
Ann Arbor 167
Wilmington 159
Altamura 146
Los Angeles 132
Andover 128
The Dalles 125
Lawrence 123
Brussels 112
Ho Chi Minh City 109
New York 103
Munich 99
Piscataway 80
Fremont 76
Tokyo 73
Des Moines 68
Hanoi 60
São Paulo 60
Saint Petersburg 57
Turku 54
Orem 50
Warsaw 48
West Jordan 48
Izmir 45
Nanjing 43
Redmond 43
Norwalk 39
Dallas 38
Brooklyn 36
Dearborn 36
Helsinki 35
Woodbridge 35
Council Bluffs 33
Denver 32
Rome 31
Atlanta 30
Falls Church 27
Baghdad 26
Bucharest 25
Chicago 25
Spoleto 25
Chennai 24
Columbus 24
Hefei 24
Montreal 24
Poplar 24
San Giustino 23
Tashkent 23
London 22
San Paolo di Civitate 22
Shanghai 22
Houston 21
Redwood City 21
Stockholm 21
Dhaka 20
Johannesburg 20
Phoenix 20
San Diego 18
San Francisco 18
Seattle 18
Ankara 17
Philadelphia 17
Rio de Janeiro 17
Den Haag 16
Mexico City 16
Mumbai 16
Buffalo 15
Secaucus 15
Auburn Hills 14
Boston 14
Charlotte 14
Chongqing 14
Da Nang 14
Manchester 14
Abidjan 13
Curitiba 13
Hanover 13
Olomouc 13
Porto Alegre 13
Addis Ababa 12
Barnet 12
Guangzhou 12
Haiphong 12
Totale 12.739
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 332
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 329
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 317
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 314
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 249
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 200
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 181
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 164
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 160
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 154
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 145
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 144
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 142
New Insights on KCa3.1 Channel Modulation 142
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 141
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 140
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 139
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 139
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 138
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 137
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 136
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 135
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 133
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 132
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 132
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 131
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 130
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 129
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 128
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 127
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 126
6-Aminoquinolones as New Potential Anti-HIV Agents 125
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 124
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 124
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 124
6-Desfluoroquinolones as promising HIV transcription inhibitors 123
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 123
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 122
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 122
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 121
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 119
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 118
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 118
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 115
S. aureus NorA efflux pump: the discovery of new potent inhibitors 115
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 115
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 115
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 115
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 115
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 114
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 113
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 113
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 112
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 111
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 110
A New Derivative with Ultra-Potent Anti-HIV Activity 109
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 109
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 109
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 109
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 108
A new 6-aminoquinolone compound with anti-HCMV activity 108
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 107
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 107
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 105
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 105
The antibacterial activity of quinolones against E.coli: a chemometric study 105
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 104
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 104
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 103
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 101
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 101
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 101
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 101
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 100
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 100
QSAR study and VolSurf characterization of anti-HIV quinolone library 99
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 98
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 97
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 96
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 96
6-Aminoquinolones targeting HCV NS5B polymerase. 96
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 94
One-Pot Synthesis of Rufloxacin 94
In Vitro Activities of New Quinolones Against Helicobacter pylori 93
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 93
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 92
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Totale 12.705
Categoria #
all - tutte 84.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021738 0 0 0 0 0 0 0 0 0 68 147 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.419 51 287 122 298 403 167 289 194 591 199 545 273
2025/20266.531 497 452 341 884 923 667 1.158 369 742 498 0 0
Totale 20.878